Skip to content

Clinical trials

Pancreatic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Country / region: Japan Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20042
20052
20061
20075
20083
20093
20101
20113
20122
20134
20144
20154
20166
20174
20182
20191
20205
20216
20224
20234
20249
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting17
Active, not recruiting16
Unknown status11
Terminated4
Approved for marketing1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wakayama Medical University9
Eli Lilly and Company7
Fukushima Medical University4
Astellas Pharma Global Development, Inc.3
AstraZeneca3
Boehringer Ingelheim3
Novartis Pharmaceuticals3
Ono Pharmaceutical Co., Ltd.3
Pfizer3
Revolution Medicines, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms89
Carcinoma, Non-Small-Cell Lung16
Colorectal Neoplasms12
Neoplasms10
Ovarian Neoplasms10
Breast Neoplasms8
Esophageal Neoplasms8
Stomach Neoplasms8
Endometrial Neoplasms7
Bile Duct Neoplasms6

Trials

Showing 76 to 89 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.